Published in J Am Acad Dermatol on June 01, 1990
Transforming pain medicine: adapting to science and society. Eur J Pain (2013) 0.76
A case of mycosis fungoides and lymphomatoid papulosis occurring simultaneously in a child. J Clin Aesthet Dermatol (2012) 0.75
Evaluation of T-cell receptor gene rearrangements in patients with recurrent patch/plaque (T2) CTCL (mycosis fungoides). Yale J Biol Med (2001) 0.75
Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. N Engl J Med (1996) 10.60
APC mutations occur early during colorectal tumorigenesis. Nature (1992) 9.50
The efficacy of infection surveillance and control programs in preventing nosocomial infections in US hospitals. Am J Epidemiol (1985) 6.94
THE PREPARATION AND ABSORPTION SPECTRA OF FIVE PURE CAROTENOID PIGMENTS. Plant Physiol (1942) 4.65
Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability. Cancer Res (1998) 4.39
Pseudomonas cepacia colonization in patients with cystic fibrosis: risk factors and clinical outcome. J Pediatr (1985) 4.26
Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals. JAMA (1995) 3.84
The nationwide nosocomial infection rate. A new need for vital statistics. Am J Epidemiol (1985) 3.70
Microsatellite instability and 8p allelic imbalance in stage B2 and C colorectal cancers. J Natl Cancer Inst (1999) 3.46
Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating beta-catenin/TCF signalling. Nat Genet (2000) 3.33
Actin mutations in dilated cardiomyopathy, a heritable form of heart failure. Science (1998) 3.22
Length of uninterrupted CGG repeats determines instability in the FMR1 gene. Nat Genet (1994) 3.22
II. The Present Position of the Surgery of the Hypertrophied Prostate. Ann Surg (1893) 3.21
National nosocomial infections surveillance system (NNIS): description of surveillance methods. Am J Infect Control (1991) 3.00
Colonization of the respiratory tract with Pseudomonas cepacia in cystic fibrosis. Risk factors and outcomes. Chest (1987) 2.97
Global carbon sinks and their variability inferred from atmospheric O2 and delta13C. Science (2000) 2.83
BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing. J Med Genet (2004) 2.75
The frequency of hereditary defective mismatch repair in a prospective series of unselected colorectal carcinomas. Am J Hum Genet (2001) 2.68
A Large Northern Hemisphere Terrestrial CO2 Sink Indicated by the 13C/12C Ratio of Atmospheric CO2. Science (1995) 2.62
Women's vulnerability to sexual assault from adolescence to young adulthood. J Adolesc Health (2000) 2.50
Hippocampal volumes in cognitively normal persons at genetic risk for Alzheimer's disease. Ann Neurol (1998) 2.48
The Choice of the Fixating Eye in Paralytic and Non-Paralytic Strabismus. Trans Am Ophthalmol Soc (1943) 2.45
Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel. Gastroenterology (2000) 2.25
Identifying patients at high risk of surgical wound infection. A simple multivariate index of patient susceptibility and wound contamination. Am J Epidemiol (1985) 2.20
Livedo vasculitis. Segmental hyalinizing vasculitis of the dermis. Arch Dermatol (1967) 2.15
Clinical and histologic spectrum of human T-cell lymphotropic virus type I-associated lymphoma involving the skin. J Am Acad Dermatol (1996) 2.14
Herpes simplex infections in hematologic malignancies. Am J Med (1972) 2.13
Phonons and the elastic moduli of collagen and muscle. Nature (1977) 2.09
Kaposi's sarcoma: a clinicopathologic study with particular reference to its relationship to the reticuloendothelial system. Medicine (Baltimore) (1965) 2.04
Denaturing high performance liquid chromatography (DHPLC) used in the detection of germline and somatic mutations. Nucleic Acids Res (1998) 1.99
Increased risk for cancer in patients with the Peutz-Jeghers syndrome. Ann Intern Med (1998) 1.96
Sequence analysis of the fragile X trinucleotide repeat: implications for the origin of the fragile X mutation. Hum Mol Genet (1994) 1.90
Connectivity and resilience of coral reef metapopulations in marine protected areas: matching empirical efforts to predictive needs. Coral Reefs (2009) 1.86
Hippocampal atrophy and apolipoprotein E genotype are independently associated with Alzheimer's disease. Ann Neurol (1998) 1.86
Generalized granuloma annulare: clinical and laboratory findings in 100 patients. J Am Acad Dermatol (1989) 1.84
Apolipoprotein E: risk factor for Alzheimer disease. Am J Hum Genet (1994) 1.83
The effect of sugar on behavior or cognition in children. A meta-analysis. JAMA (1995) 1.79
Microsatellite instability and mutation analysis of hMSH2 and hMLH1 in patients with sporadic, familial and hereditary colorectal cancer. Hum Mol Genet (1996) 1.76
Subcutaneous T-cell lymphoma. Report of two additional cases and further observations. Arch Dermatol (1993) 1.73
Analysis of a CGG sequence at the FMR-1 locus in fragile X families and in the general population. Am J Hum Genet (1993) 1.71
Evidence for a prostate cancer-susceptibility locus on chromosome 20. Am J Hum Genet (2000) 1.69
High functioning fragile X males: demonstration of an unmethylated fully expanded FMR-1 mutation associated with protein expression. Am J Med Genet (1994) 1.68
Course of dermatomyositis-polymyositis: comparison of untreated and cortisone-treated patients. Mayo Clin Proc (1968) 1.67
Cystic fibrosis and the phenotypic expression of autosomal dominant polycystic kidney disease. Am J Kidney Dis (1998) 1.64
Evidence for autosomal dominant inheritance of prostate cancer. Am J Hum Genet (1998) 1.63
I. The Results of Double Castration in Hypertrophy of the Prostate. Ann Surg (1895) 1.61
A quantitative study of Meissner's corpuscles in man. Neurology (1966) 1.55
Dermal mast cell activation by autoantibodies against the high affinity IgE receptor in chronic urticaria. J Invest Dermatol (1996) 1.54
Acanthosis nigricans: a study of 90 cases. Medicine (Baltimore) (1968) 1.50
Vasculitis and retinoids. Lancet (1989) 1.49
The location of the Philadelphia chromosomal breakpoint site and prognosis in chronic granulocytic leukemia. Leukemia (1990) 1.49
Necrotizing vasculitis and atherosclerosis. Br J Dermatol (1988) 1.49
Serum IgE in dermatitis and dermatosis: an analysis of 497 cases. Arch Dermatol (1977) 1.48
Evidence for eosinophil degranulation with deposition of granule major basic protein in solar urticaria. J Am Acad Dermatol (1989) 1.48
Histiocytic cytophagic panniculitis. J Am Acad Dermatol (1989) 1.46
Iron overload in cirrhosis-HFE genotypes and outcome after liver transplantation. Hepatology (2000) 1.45
Genotype prediction in the fragile X syndrome. J Med Genet (1991) 1.45
Paralysis of the Superior Rectus Muscle. Trans Am Ophthalmol Soc (1933) 1.43
Rapid, nonradioactive screening for mutations in exons 10, 11, and 16 of the RET protooncogene associated with inherited medullary thyroid carcinoma. Clin Chem (1997) 1.42
Cutaneous malignant melanoma in Rochester, Minnesota: trends in incidence and survivorship, 1950 through 1985. Mayo Clin Proc (1990) 1.42
Nosocomial infection surveillance, 1984. MMWR CDC Surveill Summ (1986) 1.41
Relative significance of dietary sources of nitrate and nitrite. J Agric Food Chem (1975) 1.40
Fatal systemic cytophagic histiocytic panniculitis: a histopathologic and immunohistochemical study of multiple organ sites. J Am Acad Dermatol (1994) 1.39
Cancer and scleroderma. Arch Dermatol (1979) 1.39
Genetic mapping of new DNA probes at Xq27 defines a strategy for DNA studies in the fragile X syndrome. Am J Hum Genet (1991) 1.38
Immunofluorescence of cutaneous vasculitis associated with systemic disease. Arch Dermatol (1971) 1.38
Histopathologic and immunofluorescence study of skin lesions associated with circulating lupus anticoagulant. J Am Acad Dermatol (1988) 1.38
Ophthalmic features of necrobiotic xanthogranuloma with paraproteinemia. Am J Ophthalmol (1984) 1.37
Candidate-gene association studies with pedigree data: controlling for environmental covariates. Genet Epidemiol (2003) 1.36
Localized involutional lipoatrophy: a clinicopathologic study of 16 patients. J Am Acad Dermatol (1996) 1.35
Generalized plane xanthoma and systemic disease. Arch Dermatol (1966) 1.34
Histopathologic findings in anetoderma. Arch Dermatol (1984) 1.34
Erythroderma with atypical lymphocytes. (Sézary syndrome). Am J Med (1973) 1.33
Alpha1-antitrypsin deficiency allele carriers among lung cancer patients. Cancer Epidemiol Biomarkers Prev (1999) 1.32
Quantitative studies on the Langerhans cell population of guinea pig epidermis. J Invest Dermatol (1967) 1.31
Prostaglandins and chemotaxis: enhancement of polymorphonuclear leukocyte chemotaxis by prostaglandin F2alpha. J Invest Dermatol (1976) 1.30
The genomic organization of human dystrobrevin. Neurogenetics (1997) 1.29
The premortem recognition of systemic senile amyloidosis with cardiac involvement. Am J Med (1996) 1.28
The Present Status of the Leg Length Discrepancy Problem. Ann Surg (1947) 1.28
Allelic imbalance and microsatellite instability in prostatic adenocarcinoma. Cancer Res (1996) 1.28
Higher risk of mismatch repair-deficient colorectal cancer in alpha(1)-antitrypsin deficiency carriers and cigarette smokers. Mol Genet Metab (2000) 1.28
Necrobiotic xanthogranuloma with paraproteinemia. J Am Acad Dermatol (1980) 1.28
Papulonecrotic tuberculid: a neglected disease in Western countries. J Am Acad Dermatol (1986) 1.27
Bullous pyoderma gangrenosum and leukemia. Arch Dermatol (1972) 1.27
Recent amplification of an alpha satellite DNA in humans. Nucleic Acids Res (1985) 1.25
Necrobiotic xanthogranuloma. Arch Dermatol (1992) 1.25
BRCA1 and BRCA2 have a limited role in familial prostate cancer. Cancer Res (2000) 1.25
Dermatofibrosarcoma protuberans. Study of fifty-six cases. Am J Surg (1966) 1.24
Role of HPC2/ELAC2 in hereditary prostate cancer. Cancer Res (2001) 1.24
Necrobiotic xanthogranuloma with paraproteinemia. A review of 22 cases. Medicine (Baltimore) (1986) 1.24
Genetic and physical mapping of a novel region close to the fragile X site on the human X chromosome. Genomics (1989) 1.24
Intravenous immunoglobulin in autoimmune chronic urticaria. Br J Dermatol (1998) 1.24
Panniculitis in connective tissue disease. Arch Dermatol (1983) 1.23
Esophageal deterioration in scleroderma. Mayo Clin Proc (1971) 1.23
The genetic basis of colorectal cancer in a population-based incident cohort with a high rate of familial disease. Gut (2010) 1.23
The gene for HMSN2C maps to 12q23-24: a region of neuromuscular disorders. Neurology (2003) 1.22
The Merkel cell. J Invest Dermatol (1973) 1.22